Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue
+34.1%
EPS
+34.4%
Free cash flow
−85.8%
Total debt
−0.06%

Quarter to September 2026, against a year earlier

365.77 25.26 −6.46%
Market cap
$52.4B
P/E
0.0×
Fwd P/E
−289×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a

Natera, Inc. (NTRA) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Natera, Inc. (NTRA) trades at a P/B ratio of 28.2×. Over the past ten years it has ranged from 0.0× (September 2018) to 348× (June 2019); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 18.3× 10.75%
FY2024 16.5× 77.51%
FY2023 9.3× 73.36%
FY2022 5.4× (58.54%)
FY2021 12.9× (21.93%)
FY2020 16.6× 97.21%
FY2019 8.4× (66.52%)
FY2018 25.1× 26.41%
FY2017 19.9× 244.88%
FY2016 5.8× 276.01%

Quarterly newest first

Period P/B ratio Change
Sep 2026 31.8× 49.16%
Jun 2026 21.4× 33.85%
Mar 2026 16.0× (12.79%)
Dec 2025 18.3× 3.72%
43 more quarters

Against its own ten years

Low 0.0× High 348×
Ten-year median 13.2×
Current reading's percentile 91

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on NTRA